Catalyst Wire Dossier Catalyst Wire Dossier

Leustatin

cladribine
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Leustatin, covering 2012-05-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL) [Phase 2]

See pricing